Skip to main content
Back to feed
HealthSingle-sourceLow
2.1

Brazil's SUS reports 33,000 patients treated with Tafenoquina for malaria

The Brazilian Unified Health System (SUS) has administered Tafenoquina to over 33,000 patients as of June 2026. The drug represents a significant shift in malaria treatment protocols, though the long-term impact on national transmission rates remains to be fully quantified.

Poder3603 days agoBRCredibility 45%View source

Score Breakdown

Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.5

Intelligence Tags

#malaria#public health#brazil#pharmaceuticals#sus

Locations

Brazil

Entities

country
Source

Related signals

8 found